tm
Seeing Is Believing
tm
Seeing Is Believing
BCAX is currently covered by 9 analysts with an average price target of $32. This is a potential upside of $14.93 (87.46%) from yesterday's end of day stock price of $17.07.
Bicara Therapeutics's activity chart (see below) currently has 22 price targets and 43 ratings on display. The stock rating distribution of BCAX is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 26.48% with an average time for these price targets to be met of 49.17 days.
Highest price target for BCAX is $46, Lowest price target is $16, average price target is $32.
Most recent stock forecast was given by JEET MUKHERJEE from BTIG on 19-Oct-2026. First documented stock forecast 08-Oct-2024.
Currently out of the existing stock ratings of BCAX, 8 are a HOLD (33.33%), 16 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jan-2026
$39
$21.93 (128.47%)
$39
8 days ago
(19-Oct-2026)
2/4 (50%)
$21.53 (123.24%)
169
Buy Since 06-Feb-2025
$33
$15.93 (93.32%)
$30
2 months 15 days ago
(12-Aug-2026)
2/5 (40%)
$8.37 (33.98%)
137
Hold Since 18-Dec-2025
$20
$2.93 (17.16%)
$18
2 months 15 days ago
(12-Aug-2026)
2/2 (100%)
$-4.63 (-18.80%)
24
Hold Since 31-Mar-2026
$20
$2.93 (17.16%)
$18
2 months 15 days ago
(12-Aug-2026)
2/3 (66.67%)
$-4.63 (-18.80%)
93
Hold Since 11-Nov-2025
$23
$5.93 (34.74%)
$16
2 months 15 days ago
(12-Aug-2026)
1/5 (20%)
$-1.63 (-6.62%)
30
What is BCAX (Bicara Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on BCAX (Bicara Therapeutics)?
Which analyst has the most public recommendations on BCAX (Bicara Therapeutics)?
Which analyst is the currently most bullish on BCAX (Bicara Therapeutics)?
Which analyst is the currently most reserved on BCAX (Bicara Therapeutics)?
